Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

BUY
$3.54 - $8.3 $14,839 - $34,793
4,192 Added 5.59%
79,132 $320,000
Q4 2021

Feb 14, 2022

BUY
$7.69 - $19.66 $3,076 - $7,864
400 Added 0.54%
74,940 $600,000
Q3 2021

Nov 15, 2021

BUY
$12.22 - $21.28 $41,548 - $72,352
3,400 Added 4.78%
74,540 $1.44 Million
Q2 2021

Aug 16, 2021

BUY
$9.0 - $15.94 $640,260 - $1.13 Million
71,140 New
71,140 $982,000

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.